Home / Brands / Clinical Specialties Compounding Pharmacy
Clinical Specialties Compounding Pharmacy Recalls
50 recalls on record · July 10, 2013 to September 4, 2013 · Drugs
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Latanoprost 0.025% eye drop, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Laser ophthalmic drops, 12 mL bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Itraconazole 1% eye ointment, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Injection vehicle, 120 ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Hydroxyprogesterone 250 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls HCG 500 units/ml, 10 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls HCG 2000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls HCG 1000 units/ml, 30 mL syringe, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Gentamicin buffered 36.4 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Estradiol Valerate 30 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Estradiol Valerate 20 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Estradiol Cypionate 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Diazepam 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Cyclosporine 2% ophthalmic, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Cyclosporine 1% ophthalmic drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Cataract drops, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Acetylcysteine 2 % Solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Acetylcysteine 20 % solution, 100 ml bottle, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 309
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
July 10, 2013DrugsFDA
Clinical Specialties Compounding Pharmacy recalls Acetylcysteine 10 % Solution, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes